GABBR2
MOLECULAR TARGETgamma-aminobutyric acid type B receptor subunit 2
GABBR2 (gamma-aminobutyric acid type B receptor subunit 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GABBR2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gamma-Aminobutyric Acid | 2.20 | 8 |
About GABBR2 as a Drug Target
GABBR2 (gamma-aminobutyric acid type B receptor subunit 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented GABBR2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GABBR2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.